Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Multimodal imaging of the biphasic corneal wound healing response to topical acrolein exposure
Author Affiliations & Notes
  • Jonathan Lin
    Ophthalmology and Visual Sciences, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
    Pharmacology & Toxicology, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Zhongqiao Lu
    Ophthalmology and Visual Sciences, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Anne C Chan
    Ophthalmology and Visual Sciences, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Metha R Chea
    Ophthalmology and Visual Sciences, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Shuizhen Shi
    Ophthalmology and Visual Sciences, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Fan Xia
    Ophthalmology and Visual Sciences, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Jonathan Luisi
    Pharmacology & Toxicology, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Bartosz Szczesny
    Ophthalmology and Visual Sciences, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Kevin Merkley
    Ophthalmology and Visual Sciences, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Bill T Ameredes
    Pharmacology & Toxicology, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Praveena K Gupta
    Ophthalmology and Visual Sciences, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Hua Liu
    Ophthalmology and Visual Sciences, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Wenbo Zhang
    Ophthalmology and Visual Sciences, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Massoud Motamedi
    Ophthalmology and Visual Sciences, The University of Texas Medical Branch at Galveston, Galveston, Texas, United States
  • Footnotes
    Commercial Relationships   Jonathan Lin None; Zhongqiao Lu None; Anne Chan None; Metha Chea None; Shuizhen Shi None; Fan Xia None; Jonathan Luisi None; Bartosz Szczesny None; Kevin Merkley None; Bill Ameredes None; Praveena Gupta None; Hua Liu None; Wenbo Zhang None; Massoud Motamedi None
  • Footnotes
    Support  NIEHS Grant T32ES007254, NIH Grant EY034266, UT System Faculty STARs Award
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2025. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jonathan Lin, Zhongqiao Lu, Anne C Chan, Metha R Chea, Shuizhen Shi, Fan Xia, Jonathan Luisi, Bartosz Szczesny, Kevin Merkley, Bill T Ameredes, Praveena K Gupta, Hua Liu, Wenbo Zhang, Massoud Motamedi; Multimodal imaging of the biphasic corneal wound healing response to topical acrolein exposure. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2025.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Acrolein (Acr) is an aldehyde that is used in a variety of manufacturing processes, as a chemical feedstock for the generation of acrylic acid and other organic chemicals, and as a biocide for clearing waterways. Notably, Acr was previously used as a chemical warfare agent, contributing to its listing as a chemical of concern due to the risk of accidental spillage or use by terrorists. Given the potential for exposure to acrolein, this study aimed to characterize ocular changes induced by topical Acr exposure through longitudinal monitoring of corneal response with multimodal imaging.

Methods : Following an IACUC-approved protocol, a murine model of ocular Acr exposure at 2.5 mg/mL for 30s was performed. Anterior segment optical coherence tomography, OCT angiography, slit lamp biomicroscopy, and in vivo corneal confocal microscopy (IVCM) were performed prior to the injury and up to 84 days after. Eyes were enucleated for histological assessment following day 84.

Results : Topical Acr exposure resulted in acute swelling and strong opacity at 3d, which would largely recover by 7d. A low degree of opacity remained through 21d, after which swelling and opacity began to increase, worsening through to 84d. Neovascularization was observed around 14d, remaining largely unchanged at 21d, before becoming more intense while spreading into the central cornea at 42d and 84d. IVCM demonstrated irregular cell morphology in the epithelium at 3d that returned to normal by 7-14d. The stroma showed immune cell infiltration and signs of keratocyte apoptosis at 3-7d, with hyperreflective deposits of fiber-like structures, possibly indicative of fibrosis, seen as early as 21d. Acr-exposed eyes also presented with significantly enlarged and altered endothelial cells, an adaptive response to endothelial cell loss.

Conclusions : We demonstrated the biphasic nature of Acr injury in the cornea, consisting of an acute and chronic phase and unique among other chemical injuries such as alkali burn. The acute phase is characterized by early inflammation with corneal edema and opacity that largely recovers within the first week yet does not completely resolve. Additionally, limited peripheral corneal neovascularization can be seen. The chronic phase, beginning after three weeks, presents with increased neovascularization propagating into the central cornea and the recurrence of corneal opacity and swelling accompanied by fibrosis.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×